Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Anesthesiol ; 20(1): 253, 2020 09 29.
Article in English | MEDLINE | ID: mdl-32993507

ABSTRACT

BACKGROUND: Some retrospective and in vitro studies suggest that general anesthetics influence breast cancer recurrence and metastasis. We compared the effects of general anesthetics sevoflurane versus propofol on breast cancer cell survival, proliferation and invasion in vitro. The investigation focused on effects in intracellular Ca2+ homeostasis as a mechanism for general anesthetic-mediated effects on breast cancer cell survival and metastasis. METHODS: Estrogen receptor-positive (MCF7) and estrogen receptor-negative (MDA-MB-436) human breast cancer cell lines along with normal breast tissue (MCF10A) were used. Cells were exposed to sevoflurane or propofol at clinically relevant and extreme doses and durations for dose- and time-dependence studies. Cell survival, proliferation and migration following anesthetic exposure were assessed. Intracellular and extracellular Ca2+ concentrations were modulated using Ca2+ chelation and a TRPV1 Ca2+ channel antagonist to examine the role of Ca2+ in mediating anesthetic effects. RESULTS: Sevoflurane affected breast cancer cell survival in dose-, time- and cell type-dependent manners. Sevoflurane, but not propofol, at equipotent and clinically relevant doses (2% vs. 2 µM) for 6 h significantly promoted breast cell survival in all three types of cells. Paradoxically, extreme exposure to sevoflurane (4%, 24 h) decreased survival in all three cell lines. Chelation of cytosolic Ca2+ dramatically decreased cell survival in both breast cancer lines but not control cells. Inhibition of TRPV1 receptors significantly reduced cell survival in all cell types, an effect that was partially reversed by equipotent sevoflurane but not propofol. Six-hour exposure to sevoflurane or propofol did not affect cell proliferation, metastasis or TRPV1 protein expression in any type of cell. CONCLUSION: Sevoflurane, but not propofol, at clinically relevant concentrations and durations, increased survival of breast cancer cells in vitro but had no effect on cell proliferation, migration or TRPV1 expression. Breast cancer cells require higher cytoplasmic Ca2+ levels for survival than normal breast tissue. Sevoflurane affects breast cancer cell survival via modulation of intracellular Ca2+ homeostasis.


Subject(s)
Anesthetics, Inhalation/pharmacology , Breast Neoplasms/pathology , Calcium/metabolism , Sevoflurane/pharmacology , Anesthetics, Intravenous/pharmacology , Cell Survival/drug effects , Female , Homeostasis , Humans , In Vitro Techniques , Neoplasm Invasiveness , Propofol/pharmacology , Tumor Cells, Cultured
2.
Molecules ; 22(7)2017 Jul 16.
Article in English | MEDLINE | ID: mdl-28714902

ABSTRACT

The ability to modulate protein function through minimal perturbations to amino acid structure represents an ideal mechanism to engineer optimized proteins. Due to the novel spectroscopic properties of green fluorescent protein, it has found widespread application as a reporter protein throughout the fields of biology and chemistry. Using site-specific amino acid mutagenesis, we have incorporated various fluorotyrosine residues directly into the fluorophore of the protein, altering the fluorescence and shifting the pKa of the phenolic proton associated with the fluorophore. Relative to wild type GFP, the fluorescence spectrum of the protein is altered with each additional fluorine atom, and the mutant GFPs have the potential to be employed as pH sensors due to the altered electronic properties of the fluorine atoms.


Subject(s)
Amino Acids/chemistry , Fluorescence , Green Fluorescent Proteins/chemistry , Biosensing Techniques , Fluorescent Dyes/chemistry , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Halogenation , Models, Molecular , Molecular Conformation , Mutation , Spectrometry, Fluorescence/methods
3.
Bioorg Med Chem Lett ; 27(1): 30-33, 2017 01 01.
Article in English | MEDLINE | ID: mdl-27894869

ABSTRACT

The ability to introduce or modify protein function has widespread application to multiple scientific disciplines. The introduction of unique unnatural amino acids represents an excellent mechanism to incorporate new functionality; however, this approach is limited by ability of the translational machinery to recognize and incorporate the chemical moiety. To overcome this potential limitation, we aimed to exploit the functionality of existing unnatural amino acids to perform bioorthogonal reactions to introduce the desired protein modification, altering its function. Specifically, via the introduction of a terminal alkyne containing unnatural amino acid, we demonstrated chemically programmable protein modification through the Glaser-Hay coupling to other terminal alkynes, altering the function of a protein. In a proof-of-concept experiment, this approach has been utilized to modify the fluorescence spectrum of green fluorescent protein.


Subject(s)
Alkynes/chemistry , Amino Acids/chemistry , Green Fluorescent Proteins/metabolism , Green Fluorescent Proteins/chemistry , Models, Molecular , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL
...